Advanced

Retatrutide

Triple Agonist (Experimental)

glp1

Retatrutide

Triple Agonist (Experimental)

Sign in to view pricing

Create an account to access exclusive member pricing

Get Started

About Retatrutide

Retatrutide is an investigational triple hormone receptor agonist that targets GLP-1, GIP, and glucagon receptors. This triple action approach may provide enhanced weight loss, improved blood sugar control, and increased fat burning compared to dual or single agonists.

Benefits

Targets 3 key metabolic hormones
Enhanced appetite control
Blood sugar regulation
Potential for greater weight loss
Fat burning activation
Once weekly dosing

Dosing Protocol

1Week 1-4: Start at 0.5mg once weekly
2Week 5-8: Increase to 1mg
3Week 9-12: Increase to 2mg
4Week 13+: Can increase to 4mg
5Follow clinician guidance for titration

Possible Side Effects

•Nausea
•Diarrhea
•Vomiting
•Decreased appetite (intended effect)

Most side effects are mild and temporary. Consult a healthcare provider if symptoms persist.

Storage Instructions

Store refrigerated. Do not freeze.

Certificate of Analysis

Every batch is independently tested for identity, purity, and potency. Contact us for COA documentation on any specific batch.

Request Lab Results